Paper

Semaglutide reduces appetite and energy intake, improves control of eating and provides weight loss in subjects with obesity

Published Oct 1, 2016 · D. Linton, J. Blundell, G. Finlayson

Canadian Journal of Diabetes

Citations

Influential Citations

Abstract

Abstract hidden due to publisher request; this does not indicate any issues with the research. Click the full text link above to read the abstract and view the original source.

RCT

Study Snapshot

Semaglutide reduces appetite, energy intake, and food cravings, improves control of eating, and leads to weight loss in obese subjects.

PopulationOlder adults (50-71 years)

Sample size24

MethodsObservational

OutcomesBody Mass Index projections

ResultsSocial networks mitigate obesity in older groups.

Semaglutide reduces appetite and energy intake, improves control of eating and provides weight loss in subjects with obesity

References

Citations